文献速递其他结缔组织病

澳大利亚多中心纵向队列中男性系统性硬化症患者的特征与结局

Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-05-03

该研究基于澳大利亚硬皮病队列2033例患者,比较男女性别在人口学、血清学和临床特征上的差异。男性患者更常见弥漫性皮肤受累、数字溃疡、间质性肺病及多种自身抗体阳性,且职业暴露更多。在病程小于4年的 incident 队列中,男性10年生存率显著低于女性(60% vs 82%,P<0.001)。

要点

  • 男性SSc患者弥漫性皮肤受累比例更高(43.7% vs 23.6%,P<0.001)。
  • 男性患者抗Scl-70、抗Jo-1、抗PM/Scl和抗RNA聚合酶III抗体阳性率更高。
  • incident队列中男性10年生存率60%,显著低于女性82%(P<0.001)。

核心结论

  • 男性SSc患者可提取性核抗原抗体阳性率更高,且生存率低于女性。
  • 性别间职业暴露差异显著,提示工业暴露可能参与男性SSc发病。

研究设计与样本

  • 回顾性观察研究,使用澳大利亚硬皮病队列研究数据,共纳入2033例参与者,其中男性299例,女性与男性比例为5.8:1。
  • 采用卡方检验、Wilcoxon秩和检验和Student t检验比较男女患者特征;用Kaplan-Meier曲线展示从诊断至全因死亡的生存分析,并用多变量Cox比例风险模型评估全因死亡的独立预测因素。
  • 对病程小于4年(从首个非雷诺现象表现至入组)的incident SSc患者进行亚组分析。

主要发现

  • 男性患者更常见弥漫性皮肤受累(43.7% vs 23.6%,P<0.001),且数字溃疡、指端凹陷、坏疽、肌腱摩擦感、肌炎和间质性肺病发生率更高。
  • 男性患者抗Scl-70、抗Jo-1、抗PM/Scl和抗RNA聚合酶III抗体阳性率高于女性。
  • 男性患者硅尘、有机溶剂、氯乙烯和环氧树脂暴露比例高于女性。
  • 在incident队列中,男性从诊断起10年生存率为60%,女性为82%(P<0.001)。

临床怎么用

  • 临床应关注男性SSc患者更常见的弥漫性皮肤受累、间质性肺病及多种自身抗体阳性,并加强筛查与监测。
  • 对男性SSc患者需详细询问硅尘、有机溶剂等职业暴露史,并警惕其生存预后较差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. METHODS: This was a retrospective observational study using data from the Australian Scleroderma Cohort Study. Male patients were compared to female patients using chi-square test, Wilcoxon rank-sum test, and Student's t-test. Survival analysis from time of diagnosis to all-cause mortality was presented on Kaplan-Meier curves, and a multivariate Cox proportional hazards model was used to evaluate independent predictors of all-cause mortality. A subanalysis of patients with incident SSc, defined as disease duration less than four years from onset of first non-Raynaud phenomenon manifestation to recruitment, was performed. RESULTS: Of the 2,033 participants, 299 were male, with a female-to-male ratio of 5.8:1. Male patients were more likely to present with diffuse skin involvement (43.7% vs 23.6%, P < 0.001) and ever be positive for digital ulcers, digital pitting, gangrene, and tendon friction rubs as well as myositis and interstitial lung disease. Male patients were more likely to have anti-Scl-70, anti-Jo-1, anti-PM/Scl and anti-RNA polymerase III antibodies compared to female patients. Male patients reported more exposure to silica dust, organic solvents, vinyl chloride, and epoxy resin compared with female patients. In the incident cohort, male patients had statistically significantly higher mortality, with 60% of male patients compared to 82% of female patients surviving 10 years from diagnosis (P < 0.001). CONCLUSION: Male patients with SSc have more extractable nuclear antigen antibody positivity and reduced survival in comparison to female patients. The significant difference between occupational exposures recorded between sexes warrants further investigation into the role of industrial exposures in the pathogenesis of SSc in male patients.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Lin E, Hansen D, Ross L, et al. Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort. Arthritis Care Res (Hoboken). 2026. PMID: 41972746. doi:10.1002/acr.80060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。